Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × ciforadenant × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 85 Carboplatin 68 Pemetrexed 53 Nivolumab 45 Docetaxel 44 Cisplatin 44 Paclitaxel 41 Erlotinib Hydrochloride 35 Radiotherapy 26 Gemcitabine 25 osimertinib 21 Cetuximab 21 Bevacizumab 19 Ipilimumab 16 Taxes 13 Cyclophosphamide 13 Radiosurgery 12 130-nm albumin-bound paclitaxel 12 avelumab 11 atezolizumab 11 durvalumab 10 Gefitinib 10 Albumin-Bound Paclitaxel 10 Radiation 8 Drug Therapy 8 Etoposide 7 trametinib 6 fludarabine 6 cemiplimab 6 Irinotecan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03337698 2025-12-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡